Marcell Csanádi

University of Ghana — GH

Economics, Econometrics and Finance · Social Sciences

19h-index1.4kcitations112works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(36), Pharmaceutical Economics and Policy(35), Colorectal Cancer Screening and Detection(16), Global Cancer Incidence and Screening(16), Hematopoietic Stem Cell Transplantation(9)

Publications112 total

HPR158 Perceived Impact and Actionability of Barriers to Drug Repurposing: Insights From a Multistakeholder Policy Survey
Value in Health·2025
The eyes of the beholder: Perceived barriers to successful drug repurposing
British Journal of Pharmacology·2025Open Access
Methodological aspects of economic evaluations and health economic models in glioblastoma: A systematic literature review
Neuro-Oncology Practice·2025Open Access
Systematic Literature Review on Economic Evaluations and Health Economic Models in Metastatic Castration-Sensitive Prostate Cancer
Current Oncology·2025· 1 citedOpen Access
CO198 Outcomes Measured in Multiple Myeloma Trials in the Past 10 Years: Focus on Minimal Residual Disease and Therapy Response
Value in Health·2025
Implementing health economics for pharmacogenomics research translation in Africa
Communications Medicine·2025· 3 citedOpen Access
The benefits of telehealth in promoting equity in blood cancer care – results of a multi-stakeholder forum and systematic literature review
Journal of Medical Economics·2025· 4 citedOpen Access
Barriers of organized cervical cancer screening in Albania and Montenegro
BMC Public Health·2025· 1 citedOpen Access
Economic evaluations and health economic models of soft tissue sarcomas: Systematic literature review from a European and North American perspective
Critical Reviews in Oncology/Hematology·2025· 1 citedOpen Access
Additional file 1 of Barriers of organized cervical cancer screening in Albania and Montenegro
Figshare·2025Open Access
SA56 Economic Evaluations and Health Economic Models of Gliomas: A Systematic Review of the Literature
Value in Health·2024
HPR155 Drug Repurposing: Policy Barriers to Using Existing Pharmaceuticals in New Indications: Results of a Systematic Literature Review
Value in Health·2024
Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study
Trials·2024· 15 citedOpen Access
A kockázatmegosztási megállapodások adminisztrációs terhei Magyarországon : Irány az automatizáció?
IME - Az egészségügyi vezetők szaklapja·2023Open Access
Roadmap to improve the organized cancer screening programs – The case of colorectal cancer screening in Montenegro
Journal of Cancer Policy·2023· 3 citedOpen Access
Goals and methods of managed entry agreements – can we get what we want?
Health Policy and Technology·2023· 5 cited
Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia
BioDrugs·2023· 6 citedOpen Access
Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy
Journal of Medical Screening·2023· 1 citedOpen Access
Development of a breast cancer screening protocol to use automated breast ultrasound in a local setting
Frontiers in Public Health·2023Open Access
A kis dózisú komputertomográfiával történő tüdőrákszűrés hazai bevezetésének kérdései
Lege Artis Medicinae·2023
page 1 of 6Next →

Frequent Co-authors

Zoltán Kaló(24), János G. Pitter(16), Harry J. de Koning(13), Zoltán Vokó(11), Martin McKee(10), Ahti Anttila(9), Carlo Senore(9), Andrea Gini(8), Piotr Ozierański(8), László Lorenzovici(8), Nereo Segnan(7), Antal Zemplényi(7), Erik E. L. Jansen(6), N. Zielonke(6), Piret Veerus(6), György Széles(6), Eveline A.M. Heijnsdijk(6), Dominika Novak Mlakar(6), Jennifer Priaulx(6), András Inotai(6)